Canada - English - Health Canada

omega laboratories limited - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 400mcg - dexmedetomidine (dexmedetomidine hydrochloride) 400mcg

Canada - English - Health Canada

omega laboratories limited - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg

United States - English - NLM (National Library of Medicine)

accord healthcare inc. - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 100 ug in 1 ml - dexmedetomidine injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. dexmedetomidine injection should be administered by continuous infusion not to exceed 24 hours. dexmedetomidine injection has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue dexmedetomidine injection prior to extubation. dexmedetomidine injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none risk summary available data from published randomized controlled trials and case reports over several decades of use with intravenously administered dexmedetomidine during pregnancy have not identified a drug-associated risk of major birth defects and miscarriage; however, the reported exposures occurred after the first trimester. most of the available data are based on studies with exposures t

Canada - English - Health Canada

accord healthcare inc - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg - miscellaneous anxiolytics sedatives and hypnotics

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orion corp. - detomidine hydrochloride 7,63 mg/ml - eq. detomidine 6,36 mg - oromucosal gel - 7,6 mg/ml - detomidine hydrochloride 7.63 mg/ml - detomidine - horse

Canada - English - Health Canada

eugia pharma inc. - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg

United States - English - NLM (National Library of Medicine)

dechra veterinary products llc - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 0.5 mg in 1 ml - indications: dexmedesed is indicated for use as a sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. dexmedesed is also indicated for use as a preanesthetic to general anesthesia in dogs and cats. contraindications: do not use dexmedesed in dogs or cats with cardiovascular disease, respiratory disorders, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue. as with all alpha2 -adrenoceptor agonists, the potential for isolated cases of hypersensitivity, including paradoxical response (excitation), exists.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - dexmedetomidine hydrochloride -